FDA Inspection 1014009 — Biomat USA, Inc.

Biomat USA, Inc. — FEI 2077834

The FDA completed an inspection of Biomat USA, Inc. on May 18, 2017 in Logan, UT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 18, 2017
Fiscal Year
2017
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Logan, UT (United States)